Hosted by
Lindsey Clayton
Medicines Safety Officer - NHS Wakefield
Introduction
Chronic obstructive pulmonary disease (COPD) affects up to three million people in the UK.
Excess sputum production is common in COPD patients, and can be difficult to clear leaving these patients potentially vulnerable to respiratory infections.
This recorded lecture reviews a mucolytic prescribing project in Wakefield CCG, and its early results.
